Drug efflux by breast cancer resistance protein is a mechanism of resistance to the benzimidazole insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924
乳腺癌耐药蛋白介导的药物外排是苯并咪唑类胰岛素样生长因子受体/胰岛素受体抑制剂BMS-536924产生耐药性的机制之一。
期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-10-0438
Hou, Xiaonan; Huang, Fei; Carboni, Joan M; Flatten, Karen; Asmann, Yan W; Ten Eyck, Cynthia; Nakanishi, Takeo; Tibodeau, Jennifer D; Ross, Douglas D; Gottardis, Marco M; Erlichman, Charles; Kaufmann, Scott H; Haluska, Paul
肿瘤
肿瘤免疫
信号转导
多发性硬化症
乳腺癌
免疫/内分泌
